Lv5
1370 积分 2023-04-12 加入
A Phase I Clinical Study of the Pharmacokinetics and Safety of Prusogliptin Tablets in Subjects with Mild to Moderate Hepatic Insufficiency and Normal Liver Function
1个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
2个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
2个月前
已完结
The Impact of Regulatory Reforms in China on Drug Lag: The Role of Clinical Development Strategies
3个月前
已完结
Current advancements in pharmacotherapy for cancer cachexia
3个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
3个月前
已完结
Beyond Ozempic: brand-new obesity drugs will be cheaper and more effective
4个月前
已完结
A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation
8个月前
已完结
A Multi‐center, Randomized, Double‐Blinded, Parallel, Active and Placebo‐Controlled Phase 3 Clinical Study of the glucokinase activator PB‐201 in Treatment‐naive Patients with Type 2 Diabetes Mellitus: A Study Protocol
8个月前
已完结
A model‐informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong‐acting dipeptidyl peptidase‐4 inhibitor
8个月前
已完结
皖公网安备34019202002308
